| VEUCX | VEUSX | VEUCX / VEUSX | |
| Total Expense Ratio | 1.50 | 0.08 | 1,875% |
| Annual Report Gross Expense Ratio | 1.85 | 0.08 | 2,313% |
| Fund Existence | 27 years | 24 years | - |
| Gain YTD | 35.034 | 27.610 | 127% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000 | 3000 | 33% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 653M | 35.3B | 2% |
| Annual Yield % from dividends | 2.57 | 2.84 | 90% |
| Returns for 1 year | 30.02 | 22.96 | 131% |
| Returns for 3 years | 59.72 | 41.65 | 143% |
| Returns for 5 years | 67.36 | 37.72 | 179% |
| Returns for 10 years | 90.31 | 62.49 | 145% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| MOAT | 103.38 | 0.73 | +0.71% |
| VanEck Morningstar Wide Moat ETF | |||
| PTIN | 31.44 | 0.19 | +0.61% |
| Pacer Trendpilot International ETF | |||
| BUFX | 21.10 | 0.05 | +0.24% |
| FT Vest Laddered Enh & Mod Buffer ETF | |||
| FYC | 93.67 | -0.33 | -0.35% |
| First Trust Small Cap Gr AlphaDEX® ETF | |||
| BBC | 35.47 | -1.13 | -3.07% |
| Virtus LifeSci Biotech Clinical Trls ETF | |||